Clinical Trials Logo

Filter by:
NCT ID: NCT03882099 Recruiting - Clinical trials for Vitamin D Deficiency

Vitamin D Level and Its Relation to Pre-eclampsia and Eclampsia

Start date: March 17, 2019
Phase:
Study type: Observational

To compare 25(OH)D level in patients with pre-eclampsia, eclampsia and normotensive pregnant women as well as to study the prevalence of Vitamin D deficiency among the 3 groups.

NCT ID: NCT03881904 Recruiting - Clinical trials for Subfertility, Female

OCP Pretreatment in PCOS Patients Undergoing ICSI Using Antagonist Protocol

Start date: June 1, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

373 women with PCOS undergoing a trial of IVF/ICSI will receive OCP from day 2 of the preceding cycle for 21 days followed by GnRH antagonist COH. Another 373 women with PCOS undergoing a trial of IVF/ICSI will start GnRH antagonist COH directly without OCP pretreatment. Both groups will be followed up for effect on ongoing pregnancy rate.

NCT ID: NCT03880864 Recruiting - Weaning Failure Clinical Trials

Lung Ultrasound for Predicting Outcome of Weaning From Mechanical Ventilation

Start date: March 7, 2019
Phase: Phase 1
Study type: Interventional

Lung aeration loss can be measured via lung ultrasound, it is a non-invasive, bed side procedure, which can be performed rapidly and facilitates a dynamic assessment of lung aeration. Aim of the work: is to determine the role of lung ultrasound score as one of the predictors of successful weaning from mechanical ventilation in ICU patients.

NCT ID: NCT03880604 Recruiting - Myoma Clinical Trials

Triple Tourniquets With or Without Tranexamic Acid for Reducing Blood Loss at Open Myomectomy

TTT
Start date: April 1, 2019
Phase: N/A
Study type: Interventional

In this study, the investigators will investigate the effectiveness of an intravenous tranexamic acid plus triple tourniquets compared with triple tourniquets alone for the reduction of blood loss at the time of myomectomy

NCT ID: NCT03880045 Recruiting - Myoma Clinical Trials

Topical Tranexamic Acid Plus Perivascular Vasopressin at the Time of Abdominal Myomectomy

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

In this study, the investigators will investigate the effectiveness of a topical tranexamic acid plus perivascular vasopressin compared with perivascular vasopressin alone for the reduction of blood loss at the time of myomectomy

NCT ID: NCT03879421 Recruiting - Keratoconus Clinical Trials

Evaluation of the Keratoconic Cornea After Corneal Collagen Cross Linking.

Start date: October 1, 2016
Phase: N/A
Study type: Interventional

Aim of work: - To detect abnormal corneal thinning in keratoconus using pachymetry maps measured by high-speed anterior segment optical coherence tomography (OCT). - To evaluate the visualization and depth of the demarcation line with anterior segment optical coherence tomography (AS-OCT) after corneal collagen cross-linking (CXL). - To compare the depth of demarcation line between epithelial-on (Epi-on) and epithelial-off (Epi-off) corneal collagen cross-linking.

NCT ID: NCT03872804 Recruiting - Vitiligo Clinical Trials

Punch Minigraft Versus Transverse Needling or Combination of Both in Treatment of Non-Segmental Vitiligo

Start date: February 1, 2019
Phase: N/A
Study type: Interventional

This study is to evaluate the effectiveness and tolerability of autologous punch minigraft, transverse needling technique or combination of both followed by narrow band ultraviolet B phototherapy (311 nm) in the treatment of patients with stable non-segmental vitiligo lesions.

NCT ID: NCT03866941 Recruiting - Clinical trials for Proportion of Acute and Chronic Abusers of Synthetic Cannibinoids Among Cases of Illicit Drugs Abuser in Studied Sites

Acute and Chronic Toxicity of Some Synthetic Cannabinoids in Assiut Psychiatric Hospitals

Start date: January 1, 2019
Phase:
Study type: Observational [Patient Registry]

Synthetic cannabinoids (SCs) are new human-made mind-altering chemicals which are similar to chemicals found in the marijuana plant; they are recent to be used recreationally, especially by young adults. This new generation of novel cannabinoid compounds have been developed to avoid drug control laws and routine cannabinoid blood tests

NCT ID: NCT03863626 Recruiting - Clinical trials for Acute Decompensated Heart Failure

Exploring Diuretics Effective Management in Acute Decompensated Heart Failure, EDEMA Trial

EDEMA
Start date: March 31, 2019
Phase: N/A
Study type: Interventional

1. Evaluate efficacy and safety of continuous infusion of IV Frusemide compared to IV shots in acute decompensated heart failure ADHF 2. Evaluate superiority of time-adjusted metolazone to morning frusemide IV shots compared to irrespective administration (at random times) to overcome diuretic resistance

NCT ID: NCT03863405 Recruiting - Clinical trials for Rheumatoid Arthritis

Metformin Use in Rheumatoid Arthritis

Start date: January 9, 2019
Phase: Phase 2
Study type: Interventional

Metformin has been used clinically for over 50 years, as a glucose lowering agent. Direct and indirect anti-inflammatory effects of metformin have been reported in animal and clinical studies, and this effect is independent of its hypoglycemic effect. Animal studies showed that metformin decreased serum C-reactive protein (CRP) level in atherogenic rabbits and decreased proinflammatory cytokines (interleukin (IL)-1β, IL-6 and tumor necrosis factor (TNF-α) in obese mice . Moreover, metformin also suppressed osteoclastogenesis ; this may partially result from decreased expression of inflammatory cytokines that promote osteoclastogenesis in the arthritic joint. The objective of this study is to evaluate the efficacy and safety of addition of metformin to standard disease modifying anti-rheumatic drugs (DMARDs) in patients with rheumatoid arthritis.